CB1 antagonist 1 |
| Katalog-Nr.GC31306 |
CB1-Antagonist 1 ist ein Antagonist des CB1-Rezeptors, der in der Erforschung des metabolischen Syndroms und Fettleibigkeit, neuroinflammatorischer StÖrungen, kognitiver StÖrungen und Psychosen, gastrointestinaler StÖrungen und kardiovaskulÄrer Erkrankungen verwendet wird.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 890037-68-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CB1 antagonist 1 is an antagonist of CB1 receptor, used in the research of metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, gastrointestinal disorders, and cardiovascular conditions.
CB1 antagonist 1 is an antagonist of CB1 receptor, used in the research of metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, gastrointestinal disorders, and cardiovascular conditions[1].
[1]. Gilbert, Eric J, et al. SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS. WO 2006060461 A1.
Average Rating: 5 (Based on Reviews and 20 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *